Concepedia

Final overall survival and long-term safety in the ENGOT-OV16/NOVA phase III trial of niraparib in patients with recurrent ovarian cancer (LBA 6)

Ursula A. Matulonis, Jørn Herrstedt, Amit M. Oza, Sven Mahner, Andrés Redondo, Dominique Berton-Rigaud, Jonathan S. Berek, Charlotte Aaquist Haslund, Frederik Marmé, Antonio González-Martı́n,

Gynecologic Oncology · 2023 · 32 citations · 0 references

Open access

Concepts

MedicineGynecologyOncologyGynecologic OncologySurgical OncologyCancer Survival AnalysisOvarian CancerOvarian Cancer PharmacotherapyOvarian NeoplasiaToxicity ManagementNiraparib TherapyOvarian Cancer ChemotherapyOvarian Cancer Clinical TrialsOvarian Cancer RecurrenceOvarian Cancer TreatmentOverall MortalityOverall Survival After RecurrenceRecurrent Ovarian Cancer